Wolverine Trading, LLC Clearside Biomedical, Inc. Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$1.0 - $1.5 $1,600 - $2,400	1,600 Added 13.79%	13,200 $15,000
Q3 2022 Nov 14, 2022	BUY	$1.08 - $1.83 $12,528 - $21,228	11,600 New	11,600 $13,000
Q3 2021 Nov 12, 2021	SELL	$4.83 - $7.2 $112,539 - $167,760	-23,300 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$2.32 - $5.38 $20,880 - $48,420	9,000 Added 62.94%	23,300 $111,000
Q1 2021 May 14, 2021	BUY	$2.24 - $4.25 $32,032 - $60,775	14,300 New	14,300 $33,000
Q2 2020 Aug 13, 2020	SELL	$1.55 - $2.41 $17,515 - $27,233	-11,300 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$1.32 - $3.77 $14,916 - $42,601	11,300 New	11,300 $20,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.